141 related articles for article (PubMed ID: 38863026)
1. Early Hydrogen-Oxygen Gas Mixture Inhalation in Patients with Aneurysmal Subarachnoid Hemorrhage (HOMA): study protocol for a randomized controlled trial.
Lin F; Li R; Chen Y; Yang J; Wang K; Jia Y; Han H; Hao Q; Shi G; Wang S; Zhao Y; Chen X
Trials; 2024 Jun; 25(1):377. PubMed ID: 38863026
[TBL] [Abstract][Full Text] [Related]
2. The REACT study: design of a randomized phase 3 trial to assess the efficacy and safety of clazosentan for preventing deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
Bruder N; Higashida R; Santin-Janin H; Dubois C; Aldrich EF; Marr A; Roux S; Mayer SA
BMC Neurol; 2022 Dec; 22(1):492. PubMed ID: 36539711
[TBL] [Abstract][Full Text] [Related]
3. Non-steroidal anti-inflammatory drugs in the pathophysiology of vasospasms and delayed cerebral ischemia following subarachnoid hemorrhage: a critical review.
Solar P; Mackerle Z; Joukal M; Jancalek R
Neurosurg Rev; 2021 Apr; 44(2):649-658. PubMed ID: 32124117
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Statins in Cerebral Vasospasm, Mortality, and Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Shen J; Shen J; Zhu K; Zhou H; Tian H; Yu G
World Neurosurg; 2019 Nov; 131():e65-e73. PubMed ID: 31295598
[TBL] [Abstract][Full Text] [Related]
5. Effect of early stellate ganglion block in cerebral vasospasm after aneurysmal subarachnoid hemorrhage (BLOCK-CVS): study protocol for a randomized controlled trial.
Jing L; Wu Y; Liang F; Jian M; Bai Y; Wang Y; Liu H; Wang A; Chen X; Han R
Trials; 2022 Nov; 23(1):922. PubMed ID: 36333751
[TBL] [Abstract][Full Text] [Related]
6. Effects of post-interventional antiplatelet therapy on angiographic vasospasm, delayed cerebral ischemia, and clinical outcome after aneurysmal subarachnoid hemorrhage: a single-center experience.
Ditz C; Machner B; Schacht H; Neumann A; Schramm P; Tronnier VM; Küchler J
Neurosurg Rev; 2021 Oct; 44(5):2899-2912. PubMed ID: 33492514
[TBL] [Abstract][Full Text] [Related]
7. Dual antiplatelet therapy in aneurysmal subarachnoid hemorrhage: association with reduced risk of clinical vasospasm and delayed cerebral ischemia.
Nagahama Y; Allan L; Nakagawa D; Zanaty M; Starke RM; Chalouhi N; Jabbour P; Brown RD; Derdeyn CP; Leira EC; Broderick J; Chimowitz M; Torner JC; Hasan D
J Neurosurg; 2018 Sep; 129(3):702-710. PubMed ID: 29099296
[TBL] [Abstract][Full Text] [Related]
8. The clinical impact and safety profile of high-dose intra-arterial verapamil treatment for cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
Mao G; Gigliotti MJ; Esplin N; Sexton K
Clin Neurol Neurosurg; 2021 Mar; 202():106546. PubMed ID: 33588359
[TBL] [Abstract][Full Text] [Related]
9. Electroencephalography for detection of vasospasm and delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a retrospective analysis and systematic review.
Scherschinski L; Catapano JS; Karahalios K; Koester SW; Benner D; Winkler EA; Graffeo CS; Srinivasan VM; Jha RM; Jadhav AP; Ducruet AF; Albuquerque FC; Lawton MT
Neurosurg Focus; 2022 Mar; 52(3):E3. PubMed ID: 35231893
[TBL] [Abstract][Full Text] [Related]
10. Acute impairment of saccadic eye movements is associated with delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
Rowland MJ; Garry P; Westbrook J; Corkill R; Antoniades CA; Pattinson KTS
J Neurosurg; 2017 Oct; 127(4):754-760. PubMed ID: 27935361
[TBL] [Abstract][Full Text] [Related]
11. Associations between endothelin polymorphisms and aneurysmal subarachnoid hemorrhage, clinical vasospasm, delayed cerebral ischemia, and functional outcome.
Griessenauer CJ; Starke RM; Foreman PM; Hendrix P; Harrigan MR; Fisher WS; Vyas NA; Lipsky RH; Lin M; Walters BC; Pittet JF; Mathru M
J Neurosurg; 2018 May; 128(5):1311-1317. PubMed ID: 28548598
[TBL] [Abstract][Full Text] [Related]
12. Serum Alkaline Phosphatase Level is Associated with Angiographic Vasospasm, Delayed Cerebral Ischemia-Caused Clinical Deterioration, and Functional Outcome After Aneurysmal Subarachnoid Hemorrhage.
Zhu Y; Jiang H; Li Y; Weng Y; Xu K; Zhou L; Lin H; Sun T; Cheng D; Shen J; Zeng J; Ye D; Wang D; Zhan R
Neurocrit Care; 2019 Dec; 31(3):466-475. PubMed ID: 31016639
[TBL] [Abstract][Full Text] [Related]
13. Economic and Humanistic Burden of Cerebral Vasospasm and Its Related Complications after Aneurysmal Subarachnoid Hemorrhage: A Systematic Literature Review.
Thompson JC; Chalet FX; Manalastas EJ; Hawkins N; Sarri G; Talbot DA
Neurol Ther; 2022 Jun; 11(2):597-620. PubMed ID: 35441974
[TBL] [Abstract][Full Text] [Related]
14. Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients.
Endo H; Hagihara Y; Kimura N; Takizawa K; Niizuma K; Togo O; Tominaga T
J Neurosurg; 2022 Dec; 137(6):1707-1717. PubMed ID: 35364589
[TBL] [Abstract][Full Text] [Related]
15. Effect of intrathecal milrinone injection via lumbar catheter on delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
Koyanagi M; Fukuda H; Lo B; Uezato M; Kurosaki Y; Sadamasa N; Handa A; Chin M; Yamagata S
J Neurosurg; 2018 Mar; 128(3):717-722. PubMed ID: 28298035
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of cilostazol-nimodipine combined therapy on delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage: a prospective, randomised, double-blinded, placebo-controlled trial protocol.
Dawley T; Claus CF; Tong D; Rajamand S; Sigler D; Bahoura M; Garmo L; Soo TM; Kelkar P; Richards B
BMJ Open; 2020 Oct; 10(10):e036217. PubMed ID: 33020083
[TBL] [Abstract][Full Text] [Related]
17. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of cerebral blood flow velocities during treatment for delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage.
Rouanet C; Chaddad F; Freitas F; Miranda M; Vasconcellos N; Valiente R; Muehlschlegel S; Silva GS
Neurocrit Care; 2022 Feb; 36(1):226-239. PubMed ID: 34286467
[TBL] [Abstract][Full Text] [Related]
19. Real-world data of clazosentan in combination therapy for aneurysmal subarachnoid hemorrhage: a multicenter retrospective cohort study.
Muraoka S; Asai T; Fukui T; Ota S; Shimato S; Koketsu N; Nishizawa T; Araki Y; Saito R
Neurosurg Rev; 2023 Aug; 46(1):195. PubMed ID: 37555872
[TBL] [Abstract][Full Text] [Related]
20. Nicardipine Prolonged Release Implants for Prevention of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.
Akbik F; Waddel H; Jaja BNR; Macdonald RL; Moore R; Samuels OB; Sadan O
J Stroke Cerebrovasc Dis; 2021 Oct; 30(10):106020. PubMed ID: 34365121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
